Condition
Freezing of Gait Symptoms in Parkinson Disease
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 5 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
5 shownPharmacologically Modulating the Noradrenergic Arousal System to Reduce Freezing of Gait in Parkinson's Disease: a Multi-centre and Multi-modal ApproachNCT07316296 · 2026-01-01
RECRUITINGTURN-IT FOG: Improving Turning and Freezing of Gait in People With PDNCT06815302 · 2025-06-02
RECRUITINGPedunculopontine Nucleus Transcranial Ultrasound Stimulation as a Treatment of Freezing of Gait in Parkinson's DiseaseNCT07695233 · 2024-05-17
RECRUITINGCnF-DBS for Levodopa-Resistant FOGNCT07781696 · 2026-09-01
NOT_YET_RECRUITINGA System to Help With Freezing of Gait in Parkinson's PatientsNCT07542743 · 2026-06-01
NOT_YET_RECRUITINGCommon interventions
Leading sponsors
Trial status mix
RECRUITING3
NOT_YET_RECRUITING2
Phase mix
NA4
PHASE31
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.